Clarivate PLC

Chart & Performance

D1W1MN

P/E

—

P/S

1.37

EPS

—

Div Yield, %

2.09%

Shrs. gr., 5y

17.08%

Rev. gr., 5y

22.11%

Revenues

2.63b

-1.17%

Net income

-911m

L-76.99%

CFO

744m

+46.12%

Earnings

Feb 25, 2025

Profile

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.

URL

https://clarivate.com/

IPO date

Oct 29, 2018

Employees

11,600

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2023‑12	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12
Income
Revenues	2,628,800 -1.17%	2,659,800 0.00%	2,659,800 41.71%
Cost of revenue	906,400	954,000	954,000
Unusual Expense (Income)
NOPBT	1,722,400	1,705,800	1,705,800
NOPBT Margin	65.52%	64.13%	64.13%
Operating Taxes	(101,300)	(28,900)	(28,900)
Tax Rate
NOPAT	1,823,700	1,734,700	1,734,700
Net income	(911,200) -76.99%	(3,960,200) 0.00%	(3,960,200) 1,364.31%
Dividends	(75,500)	(75,400)	(18,868)
Dividend yield	1.21%	1.33%	0.13%
Proceeds from repurchase of equity	(100,000)	(169,300)	(169,300)
BB yield	1.61%	2.99%	1.12%
Debt
Debt current	48,800	26,700	26,700
Long-term debt	4,847,500	5,176,500	5,176,500
Deferred revenue	38,700	38,500	38,500
Other long-term liabilities	41,900	140,100	140,100
Net debt	4,507,900	4,807,200	4,852,443
Cash flow
Cash from operating activities	744,200	509,300	509,300
CAPEX	(242,500)	(202,900)	(202,900)
Cash from investing activities	(237,400)	57,300	57,300
Cash from financing activities	(496,500)	(759,200)	(759,200)
FCF	1,781,400	1,734,700	1,727,094
Balance
Cash	370,700	348,800	348,800
Long term investments	17,700	47,200	1,957
Excess cash	256,960	263,010	217,767
Stockholders' equity	5,992,300	6,812,500	6,812,500
Invested Capital	10,649,040	11,832,690	11,849,395
ROIC	16.22%	14.65%	11.78%
ROCE	15.44%	13.74%	13.78%
EV
Common stock shares outstanding	671,600	678,600	640,774
Price	9.26 11.03%	8.34 -64.54%	23.52 -20.83%
Market cap	6,219,016 9.89%	5,659,524 -62.45%	15,071,007 18.36%
EV	12,119,516	11,859,324	21,316,050
EBITDA	2,430,700	2,416,300	2,416,300
EV/EBITDA	4.99	4.91	8.82
Interest	293,700	270,300	270,300
Interest/NOPBT	17.05%	15.85%	15.85%